C25.4 Code facturable et spécifique Malignant neoplasm of endocrine pancreas

ICD-10-CM C25.4 identifies “Malignant neoplasm of endocrine pancreas” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapitre 2: Neoplasms

Instructions du code

Inclusion terms1

Malignant neoplasm of islets of Langerhans

Use additional code1

code to identify any functional activity.

Instructions des niveaux supérieurs

C25 · Malignant neoplasm of pancreas

Use additional code2
  • code to identify:
  • alcohol abuse and dependence (F10.-)
Code also1

if applicable exocrine pancreatic insufficiency (K86.81)

Chapitres 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C15-C26 · Malignant neoplasms of digestive organs (C15-C26)

Excludes 11

Kaposi's sarcoma of gastrointestinal sites (C46.4)

Excludes 21

gastrointestinal stromal tumors (C49.A-)

Références de l’index officiel

Références de l’index officiel (22)

Adenocarcinoma (2)
Carcinoma(malignant) (2)
Gastrinoma (2)
Glucagonoma (2)
Insulinoma (2)
Neoplasm, neoplastic (4)
Tumor (8)
Références depuis d’autres codes (3)
Historique

Historique du code

Dernière modification enregistrée · FY2022

ModifiéInchangé
FY2022

En vigueur dès le

  • Instructions héritées modifiées

Malignant neoplasm of endocrine pancreas

Code de diagnostic facturable

CDC/NCHS · FY2022

Toutes les éditions (19)

Toutes les éditionsEn vigueur dès leHistorique du code
FY20162015-10-01Première observation
FY20172016-10-01Instructions héritées modifiées
FY20182017-10-01Aucun changement tabulaire
FY20192018-10-01Aucun changement tabulaire
FY20202019-10-01Aucun changement tabulaire
FY2020 · April2020-04-01Aucun changement tabulaire
FY20212020-10-01Aucun changement tabulaire
FY2021 · 01-012021-01-01Aucun changement tabulaire
FY20222021-10-01Instructions héritées modifiées
FY2022 · 04-012022-04-01Aucun changement tabulaire
FY20232022-10-01Aucun changement tabulaire
FY2023 · 04-012023-04-01Aucun changement tabulaire
FY20242023-10-01Aucun changement tabulaire
FY2024 · 04-012024-04-01Aucun changement tabulaire
FY20252024-10-01Aucun changement tabulaire
FY2025 · 04-012025-04-01Aucun changement tabulaire
FY20262025-10-01Aucun changement tabulaire
FY2026 · April2026-04-01Aucun changement tabulaire
FY20272026-10-01Aucun changement tabulaire
Correspondances ICD-9 historiques · 2018

Correspondance historique uniquement ; pas de substitution automatique.

  • 157.4

Cette entrée est un code complet dans l’édition sélectionnée. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.